|Articles|August 1, 2018
- Pharmaceutical Executive-08-01-2018
- Volume 38
- Issue 8
Pharmaceutical Executive, August 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Emerging Biotech: Innovation, Location, and Inspirationabout 7 years ago
Cross-Border Funding in the Life Sciencesabout 7 years ago
Face It. You’re Not a Biotech Anymoreabout 7 years ago
The Pulse of Biopharma M&Aabout 7 years ago
The Big Apple’s Fresh Start in Biotechabout 7 years ago
‘Emerging’ Product Launch Strategiesabout 7 years ago
Biotech Investment: Reigning in Spainabout 7 years ago
Traditional Scientific Search is Brokenabout 7 years ago
Tough Fight Looms in Preserving R&D Incentivesabout 7 years ago
From Science to SuccessNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
2
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
3
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
4
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
5
